Search - tctmd.com

Displaying 121 - 140 of 334

Sort: Relevancy | Date

Presentation TCT 2015

New Randomized Trial Data (2-Year Outcomes): EVERBIO II

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

October 14, 2015

Presentation TCT 2015

New Randomized Trial Data (2-Year Outcomes): ABSORB II (TCT First Report Investigation Results and Beyond)

Presenter: Stephen G. Ellis, Patrick W. Serruys, Bernard R. Chevalier

October 14, 2015

Presentation TCT 2015

New Randomized Trial Data (1-Year Outcomes): TROFI II

Presenter: Stephen G. Ellis, Patrick W. Serruys

October 14, 2015

Presentation TCT 2015

Featured Lecture: One-Year Patient-Level Pooled Meta-analysis From 4 ABSORB Trials in 3389 Randomized Patients

Presenter: Stephen G. Ellis, Patrick W. Serruys, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

New Randomized Trial Data (1-Year Outcomes): ABSORB III (TCT Late-Breaking Clinical Trial Results and Beyond)

Presenter: Stephen G. Ellis, Patrick W. Serruys, Dean J. Kereiakes

October 14, 2015

Presentation TCT 2015

New Randomized Trial Data (1-Year Outcomes): ABSORB China (TCT Late-Breaking Clinical Trial Results and Beyond)

Presenter: Stephen G. Ellis, Patrick W. Serruys, Run-Lin Gao

October 14, 2015

Presentation TCT 2015

New Randomized Trial Data (1-Year Outcomes): ABSORB Japan (ESC Late-Breaking Trial Results and Beyond)

Presenter: Stephen G. Ellis, Patrick W. Serruys, Takeshi Kimura

October 14, 2015

Presentation TCT 2015

Comparative Outcomes of Absorb BVS in the Real-world: Insights From GHOST-EU and XIENCE V USA

Presenter: Stephen G. Ellis, Patrick W. Serruys, Davide Capodanno

October 14, 2015

Presentation TCT 2015

Featured Lecture: First Report of the 5-Year Cohort B Multimodality Imaging Results (And My Clinical Predictions Based on These Findings)

Presenter: Stephen G. Ellis, Patrick W. Serruys

October 14, 2015

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Presentation TCT 2015

TCT 16: Do Overlapping Scaffolds Have an Impact on Clinical Outcome? Analysis of the ABSORB-EXTEND Single-Arm Study

Presenter: Stephen G. Ellis, Lorenz Raber, Pieter C. Smits

October 13, 2015

Presentation TCT 2015

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

Presenter: Stephen G. Ellis, Lorenz Raber, Kengo Tanabe

October 13, 2015

Presentation TCT 2015

TCT 14: ABSORB FIRST One-Year Clinical Outcomes From a Prospective, Multicenter, Global, Real-world Registry

Presenter: Stephen G. Ellis, Lorenz Raber, Ashok Seth

October 13, 2015

Presentation TCT 2015

TCT 13: Clinical Outcomes After Implantation of Absorb BVS in Small Vessels Results From the Italian RAI Multicenter Registry

Presenter: Stephen G. Ellis, Lorenz Raber, Giulia Masiero

October 13, 2015

Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

Presenter: Ioanna Kosmidou, Bernard R. Chevalier

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

Advertisement

New Randomized Trial Data (2-Year Outcomes): EVERBIO II

New Randomized Trial Data (2-Year Outcomes): ABSORB II (TCT First Report Investigation Results and Beyond)

New Randomized Trial Data (1-Year Outcomes): TROFI II

Featured Lecture: One-Year Patient-Level Pooled Meta-analysis From 4 ABSORB Trials in 3389 Randomized Patients

New Randomized Trial Data (1-Year Outcomes): ABSORB III (TCT Late-Breaking Clinical Trial Results and Beyond)

New Randomized Trial Data (1-Year Outcomes): ABSORB China (TCT Late-Breaking Clinical Trial Results and Beyond)

New Randomized Trial Data (1-Year Outcomes): ABSORB Japan (ESC Late-Breaking Trial Results and Beyond)

Comparative Outcomes of Absorb BVS in the Real-world: Insights From GHOST-EU and XIENCE V USA

Featured Lecture: First Report of the 5-Year Cohort B Multimodality Imaging Results (And My Clinical Predictions Based on These Findings)

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

TCT 16: Do Overlapping Scaffolds Have an Impact on Clinical Outcome? Analysis of the ABSORB-EXTEND Single-Arm Study

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

TCT 14: ABSORB FIRST One-Year Clinical Outcomes From a Prospective, Multicenter, Global, Real-world Registry

TCT 13: Clinical Outcomes After Implantation of Absorb BVS in Small Vessels Results From the Italian RAI Multicenter Registry

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content